Carbapenemase Gene Spread in Enterobacter cloacae

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae is an important component of the broader carbapenem-resistant Enterobacterales problem. The organism can acquire carbapenemase-encoding genes, or CEGs, through mobile genetic elements and plasmids, creating a surveillance challenge that extends beyond resistance to a single antimicrobial class. The reference paper by Chen and colleagues examined this problem in isolates collected from eight teaching hospitals in Guangdong province, China, between December 2022 and June 2024. The study is available as an open-access article in BMC Microbiology.^{Chen et al., 2025}

The research question was not simply how often carbapenem resistance occurred. Instead, the investigators asked how CEGs were distributed between chromosomes and plasmids, whether they showed evidence of transfer potential, which mobile genetic elements accompanied them, and whether the bacterial isolates showed patterns consistent with clonal relatedness across hospitals and clinical departments. The authors also assessed whether CEG-positive isolates displayed broader antimicrobial resistance than CEG-negative isolates.

The study places these questions in the context of the COVID-19 pandemic and its associated changes in antibiotic exposure, healthcare delivery, and patient complexity. However, the sampling period began in late 2022, and the study did not provide a matched pre-pandemic comparator. Therefore, the pandemic is best understood as the epidemiological context motivating the work rather than a factor demonstrated to have caused the observed gene distribution.

Key Innovation from the Reference Study

The central innovation is the integration of several evidence layers in one regional collection. Many surveillance studies report the prevalence of resistance genes, while others focus on antimicrobial susceptibility or strain typing. Chen et al. combined gene detection with an assessment of chromosomal versus plasmid location, transfer experiments, mobile genetic element profiling, antimicrobial susceptibility testing, and ERIC-PCR-based genotyping.^{Reference study}

This combination matters because gene presence alone does not establish the same epidemiological risk in every isolate. A gene located on a plasmid may have a different dissemination potential from a chromosomal copy, although that potential depends on plasmid structure, host range, stability, selection pressure, and the surrounding genetic environment. Similarly, two isolates with the same carbapenemase gene may represent unrelated acquisitions, a shared mobile element, or expansion of a related bacterial lineage.

The study therefore moves beyond a single prevalence estimate. It presents a layered view of resistance in which genetic location, mobility, and strain relatedness are considered together. This is particularly relevant to Gram-negative bacterial infection research, where clinically important resistance determinants can move between bacterial hosts and coexist with additional resistance mechanisms.

Conceptual Study Design and Evidence Scope

The investigators analyzed 54 CREC isolates from eight teaching hospitals. The study used PCR-based detection to identify selected CEGs and a variable-temperature SDS plasmid elimination approach to help infer whether genes were associated with plasmid or chromosomal material. These methods provide a practical epidemiological framework, but they are not equivalent to complete genome sequencing or definitive physical mapping of every resistance determinant.

Broth microdilution was used to compare antimicrobial susceptibility between CEG-positive and CEG-negative groups. The study assessed imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin. Plasmid conjugation experiments, followed by PCR analysis, were used to evaluate whether detected CEGs could be transferred under the study's experimental system. The authors also identified six mobile genetic elements and used ERIC-PCR with NTSYS software to categorize strain patterns.

Conceptually, the design addresses three related but distinct questions. First, detection and inferred localization address where resistance determinants reside. Second, conjugation results address whether transfer was observed in an experimental model. Third, ERIC-PCR patterns address whether isolates share similarity at the level detectable by a fingerprinting method. These are complementary forms of evidence, but none alone proves a transmission chain between patients or hospitals.

Core Findings and Why They Matter

High prevalence of carbapenemase-encoding genes

CEGs were detected in 46 of 54 isolates, corresponding to 85.19%. The predominant pattern involved bla_NDM-1. Eighteen isolates, or 33.33% of the full collection, carried bla_NDM-1 on both chromosomal and plasmid-associated material. A further 25 isolates, or 46.30%, carried bla_NDM-1 exclusively in the plasmid-associated category reported by the study. Two isolates carried only bla_IMP on plasmids, while one carried both bla_NDM-1 and bla_KPC-2 on plasmids.^{Chen et al., 2025}

The distribution suggests that plasmid-associated bla_NDM-1 was a major feature of this regional CREC collection. It also illustrates why a simple organism-level label such as carbapenem-resistant E. cloacae is insufficient for surveillance interpretation: isolates can differ in the number, location, and mobility of resistance determinants even when they share the same resistance phenotype.

Transfer potential was common in the reported assay

Transfer of CEGs was reported for 44 of 46 CEG-positive isolates, giving a success rate of 95.65% in the study's conjugation experiments. The reported transfer rates were 42 of 44 for bla_NDM-1, 2 of 2 for bla_IMP, and 0 of 1 for bla_KPC-2.^{Reference study}

These results support the interpretation that many of the detected determinants were transferable in the experimental system. They do not, however, quantify the frequency of transfer in patients, wards, wastewater, or hospital environments. Experimental transfer is evidence of potential horizontal dissemination, not direct proof that a particular gene moved between two clinical patients.

Mobile genetic elements and strain relatedness

Six types of mobile genetic elements were identified. ISEcp1 was the most prevalent, occurring in 47 of 54 isolates, or 87.04%. Isolates carrying four mobile genetic element types simultaneously formed the largest category, accounting for 22 of 54 isolates, or 40.74%. These observations are consistent with a complex genetic background in which resistance genes may be associated with multiple mobilization contexts.

ERIC-PCR divided the 54 isolates into 17 genotypes. Types E and G were each found in 11 isolates, representing 20.37% apiece, and isolates in these groups came from different departments in five hospitals. Two type E isolates shared a Dice coefficient of 100%. This supports the presence of closely related isolates within the collection, but fingerprinting cannot establish when or where transmission occurred. A shared genotype may reflect clonal expansion, repeated acquisition of a common lineage, or limitations in the resolution of the typing method.

Resistance extended beyond carbapenems

The CEG-positive group showed significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the CEG-negative group, with reported statistical significance at P < 0.05.^{Chen et al., 2025} The supplied findings do not provide the effect size for each comparison, so the strength of the differences cannot be judged from statistical significance alone.

Biologically, the pattern is important because carbapenemase carriage may occur within a broader multidrug-resistant background. It does not mean that every CEG directly causes resistance to every listed drug. Resistance phenotypes can also involve permeability changes, efflux, target alterations, additional beta-lactamases, and other mechanisms. The study therefore supports a surveillance association rather than a complete causal model for each antimicrobial phenotype.

Comparison with Existing Internal Articles

The available internal articles approach adjacent topics from a product- and application-oriented perspective. For example, Polymyxin B Sulfate: Advanced Applications in Gram-Negati... emphasizes antimicrobial and immunological research contexts, including sepsis and bacteremia models. That focus differs from the reference paper, which does not test an intervention or establish treatment efficacy; it characterizes resistance determinants and their epidemiological behavior.

A second internal resource, Polymyxin B Sulfate: Immune Modulation and Microbiome Insight, discusses immune modulation and microbiome-related questions, including dendritic cell maturation assay contexts. Those topics may be relevant to broader Gram-negative bacterial infection research, but they should not be treated as evidence that an immunological or antimicrobial material can counter the CREC gene patterns reported by Chen et al. The reference paper supplies the stronger evidence for regional gene distribution, transfer potential, and strain relatedness.

Limitations and Transferability

The sample size was modest, with 54 isolates from one Chinese province and eight teaching hospitals. The collection may not represent community settings, non-teaching hospitals, other regions of China, or healthcare systems with different antimicrobial-use patterns. The reported frequencies should therefore be interpreted as findings from this isolate set, not as prevalence estimates for all CREC.

The study's cross-sectional or collection-based design also limits temporal inference. Although the work discusses the pandemic period, it does not demonstrate a before-and-after change attributable to COVID-19. Patient-level risk factors, antibiotic exposure histories, length of stay, ward transfers, and environmental reservoirs were not sufficient in the condensed findings to reconstruct transmission chains.

Genetic localization inferred through plasmid elimination and PCR provides useful evidence but may not resolve complete plasmid architecture, chromosomal integration sites, copy number, or linkage between all mobile elements. Whole-genome and long-read plasmid sequencing could provide higher-resolution evidence in future studies. Likewise, ERIC-PCR is useful for screening relatedness but has lower resolution than contemporary genome-based approaches.

Finally, transfer experiments demonstrate potential under a defined laboratory model rather than real-world transmission frequency. The strongest conclusion is therefore that the collection contained a high proportion of CEG-positive isolates, many with plasmid-associated bla_NDM-1 and experimentally observed transfer potential. The evidence is weaker for claims about direct patient-to-patient spread, hospital-wide outbreak pathways, or the causal effect of pandemic-era healthcare changes.

Research Support Resources

For researchers extending the antimicrobial context of this literature, Polymyxin B (sulfate) (SKU C3090) is a material mentioned in the supplied source context. It may be considered as a referenced research material, but the Chen et al. study does not establish its efficacy against the reported CREC isolates, nor does it provide a basis for clinical or experimental use recommendations.